ArticlePloS one2025
Unveiling the mechanism of Pogostemon cablin (Blanco) Benth in treating heat illnesses via network pharmacology and molecular simulation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeat illness is a dangerous condition marked by a widespread inflammatory response. Although Pogostemon cablin (Blanco) Benth and its derivatives are clinically used, their mechanisms remain unclear.
methods11 heat illness patients and 14 healthy volunteers from Southwest Medical University Affiliated Hospital were enrolled. Bulk RNA sequencing of peripheral blood samples identified disease-relevant modules via weighted gene co-expression network analysis (WGCNA). Active ingredients and targets of P. cablin were retrieved from TCMSP. GO/KEGG, protein-protein interaction (PPI), and ROC analyses were performed. Core genes were localized through single-cell RNA sequencing, with compound-target interactions validated by molecular docking.
resultsEnrichment analysis revealed nine cross-targets in TNF/NF-κB pathways. Core targets (NFKBIA, PARP1) showed high diagnostic sensitivity/specificity. Single-cell data indicated predominant expression in monocytes and CD1C-CD141 dendritic cells. Molecular docking demonstrated strong affinity of quercetin/quercimeritrin for NFKBIA/PARP1/LACTB, with molecular dynamics confirming structural stability of complexes (RMSD < 2Å after 100 ns).
conclusionThis pioneering study integrates network pharmacology and molecular simulations to elucidate P. cablin's therapeutic targets for heat illness, providing a foundation for advanced therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.